Evidence map›Paper›PMID 25640009›Full record

ArticleClinical genetics2015

Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

C L Scherr, N M Lindor, T L Malo, F J Couch, S T Vadaparampil

Abstract read
In one paragraph

Article in Clinical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

C L ScherrMoffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.ORCID http://orcid.org/0000-0001-9362-5410
N M LindorMayo Clinic Department of Health Science Research, Scottsdale, AZ, USA.
T L MaloMoffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
F J CouchMayo Clinic College of Medicine, Department of Laboratory Medicine and Pathology, Rochester, MN, USA.
S T VadaparampilMoffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Moffitt Cancer Center · USMayo Clinic · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
LINEBERGER CANCER CONTROL EDUCATION PROGRAMR25CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EARP, JO ANNE L, RIBISL, KURT M. · 1992 to 2016
$8.0M
Behavioral Oncology Education & Career DevelopmentR25CA090314 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI BRANDON, THOMAS H · 2003 to 2018
$4.0M
NCI NIH HHS CA 116201NCI NIH HHS P30 CA076292NCI NIH HHS P30-CA76292NCI NIH HHS P50 CA116201NCI NIH HHS R25 CA057726NCI NIH HHS R25 CA 090314NCI NIH HHS R25 CA090314
6 · The paper itself

Abstract

Studies indicate variant of uncertain significance (VUS) results are challenging for genetic counselors and patients, often resulting in negative patient outcomes. Genetic counselors' current practices regarding VUS are unknown. This study utilized a national survey of genetic counselors (n = 932) to examine current practices and confidence related to disclosing BRCA VUS results and reclassification information. For participants (n = 398), descriptive statistics were calculated regarding patient demographic characteristics, practices and confidence, and cross tabulation was used to identify participant's actions when receiving a reclassified VUS. Upon receiving a BRCA VUS report, the majority reported providing patients with information about the frequency with which their VUS was seen and patient ancestry, but a minority discussed DNA banking. Most were confident in their understanding of, and ability to explain, VUS results to patients, but felt less confident about achieving high levels of patient understanding. Upon reclassification, the majority reported calling the patient and mailing the results, but when the reclassification was deleterious, the majority also met with the patient face-to-face. Given the lack of standard professional guidelines about informing patients of initial and reclassified VUS results, this overview provides important insight into genetic counselors' current practices and confidence.

Indexed as

Genetic VariationAdultAgedBRCA1 ProteinBRCA2 ProteinFemaleGenetic CounselingGenetic Predisposition to DiseaseGenetic TestingHealth SurveysHumansMaleMiddle AgedMutationProfessional-Patient RelationsTruth DisclosureBRCA1 ProteinBRCA2 Proteingenetic counselinggenetic testinghereditary cancervariant of uncertain significance (VUS)VUS reclassification

Identifiers

PMID25640009
PMCPMC4522387
OpenAlexW1903039303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.